UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 Journal article
Lau, George, Obi, Shuntaro, Zhou, Jian, Tateishi, Ryosuke, Qin, Shukui, Zhao, Haitao, Otsuka, Motoyuki, Ogasawara, Sadahisa, George, Jacob, Chow, Pierce K.H., Cai, Jianqiang, Shiina, Shuichiro, Kato, Naoya, Yokosuka, Osamu, Oura, Kyoko, Yau, Thomas, Chan, Stephen L., Kuang, Ming, Ueno, Yoshiyuki, Chen, Minshan, Cheng, Ann Lii, Cheng, Gregory, Chuang, Wan Long, Baatarkhuu, Oidov, Bi, Feng, Dan, Yock Young, Gani, Rino A., Tanaka, Atsushi, Jafri, Wasim, Jia, Ji Dong, Kao, Jia Horng, Hasegawa, Kiyoshi, Lau, Patrick, Lee, Jeong Min, Liang, Jun, Liu, Zhenwen, Lu, Yinying, Pan, Hongming, Payawal, Diana A., Rahman, Salimur, Seong, Jinsil, Shen, Feng, Shiha, Gamal, Song, Tianqiang, Sun, Hui Chuan, Masaki, Tsutomu, Sirachainan, Ekaphop, Wei, Lai, Yang, Jin Mo, Sallano, Jose D., Zhang, Yanqiao, Tanwandee, Tawesak, Dokmeci, AKadir, Zheng, Shu Sen, fan, Jia, Fan, Sheung Tat, Sarin, Shiv Kumar, Omata, Masao. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024[J]. Hepatology International, 2024, 18(6), 1661-1683.
Authors:  Lau, George;  Obi, Shuntaro;  Zhou, Jian;  Tateishi, Ryosuke;  Qin, Shukui; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.9/6.6 | Submit date:2024/12/05
Hepatocellular Carcinoma  Systemic Therapy  Guidelines  The Asian Pacific Association For The Study Of The Liver  
Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer Journal article
Tang, Yuting, Wang, Ting, Hu, Yaowen, Ji, Hongli, Yan, Botao, Hu, Xiarong, Zeng, Yunli, Hao, Yifan, Xue, Weisong, Chen, Zexin, Lan, Jianqiang, Wang, Yanan, Deng, Haijun, Deng, Chuxia, Wu, Xiufeng, Yan, Jun. Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer[J]. iScience, 2023, 26(7).
Authors:  Tang, Yuting;  Wang, Ting;  Hu, Yaowen;  Ji, Hongli;  Yan, Botao; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:4.6/5.0 | Submit date:2024/01/02
Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery Journal article
Wang, Ting, Tang, Yuting, Pan, Wenjun, Yan, Botao, Hao, Yifan, Zeng, Yunli, Chen, Zexin, Lan, Jianqiang, Zhao, Shuhan, Deng, Chuxia, Zheng, Hang, Yan, Jun. Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery[J]. Diseases of the Colon and Rectum, 2023, 66(5), 733-743.
Authors:  Wang, Ting;  Tang, Yuting;  Pan, Wenjun;  Yan, Botao;  Hao, Yifan; et al.
Favorite | TC[WOS]:13 TC[Scopus]:10  IF:3.2/4.0 | Submit date:2023/06/05
Drug Tests  Patient-derived Tumor Organoid  Predictive Model  Prognostic Value  Progression-free Survival  Stage Iv Colorectal Cancer  
Anti-lung-cancer activity and liposome-based delivery systems of β-elemene Journal article
Chen,Meiwan, Zhang,Jinming, Yu,Siqin, Wang,Shengpeng, Zhang,Zaijun, Chen,Jianqiang, Xiao,Jian, Wang,Yitao. Anti-lung-cancer activity and liposome-based delivery systems of β-elemene[J]. Evidence-based Complementary and Alternative Medicine, 2012, 2012.
Authors:  Chen,Meiwan;  Zhang,Jinming;  Yu,Siqin;  Wang,Shengpeng;  Zhang,Zaijun; et al.
Favorite | TC[WOS]:15 TC[Scopus]:22  IF:2.650/3.014 | Submit date:2021/03/02